China issues white paper on COVID-19 fight

2020-06-07 10:24:14CGTN Editor : Mo Hong'e ECNS App Download

China on Sunday issued a white paper on the country's battle against COVID-19. 

The white paper, titled "Fighting COVID-19: China in Action," was issued by the State Council Information Office. 

Consisting of four chapters, the white paper explains China's prevention, control and treatment efforts in the battle against the virus, as well as the efforts made at a global level in international cooperation. 

China firmly believes that as long as all countries unite and cooperate to mount a collective response, the international community will succeed in overcoming the COVID-19 pandemic, said the white paper.

The world will "emerge from this dark moment in human history into a brighter future," said the white paper.

According to the white paper, the cure rate for COVID-19 has reached over 94 percent on the Chinese mainland.

Also, the white paper highlighted science and technology which have always been the most powerful weapon used by mankind to combat epidemics, noting that China has made full use of the weapon to win the battle against COVID-19.


China exports protective materials to 200 countries, regions: white paper

Millions of Chinese medical workers battle COVID-19 at front line: white paper

Over 3,000 COVID-19 patients aged above 80 cured in China's Hubei: white paper

China establishes strict, efficient COVID-19 information release system: white paper

Science, technology underpin China's COVID-19 fight: white paper

Chinese mainland's COVID-19 cure rate over 94 pct: white paper

TCM used in treating 92 pct COVID-19 cases in China: white paper

Temporary treatment centers a major innovative solution in China's fight against COVID-19: white paper

China believes world to emerge from COVID-19 dark moment: white paper

China gives COVID-19 patients free treatment: white paper



Most popular in 24h

MoreTop news


Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2020 All rights reserved.
Reproduction in whole or in part without permission is prohibited.